Am J Transplant, Volume 19, Suppl 3 Archives - Page 155 of 214 - ATC Abstracts

2019 American Transplant Congress
“Desens Light”: Single Center Experience Using Rituximab for High Immunologic Risk Kidney Transplant Recipients with Historic DSA
A. Casillas-Abundis, A. Tambur, A. Shetty, C. D'Agostino, J. R. Leventhal
Comprehensive Transplant Center, Northwestern Memorial Hospital, Chicago, IL
*Purpose: To evaluate the effectiveness of rituximab as induction therapy for pts undergoing kidney transplant (Tx) with historic DSA (hDSA) [Desens. Light].*Methods: 104 consecutive pts…
2019 American Transplant Congress
Induction Type Does Not Influence Kidney Graft or Patient Survival in Recipients with a Previous Heart Transplant in the United States
S. M. Riad¹, A. Tamas¹, S. Jackson², C. Martin¹
¹Medicine, University of Minnesota, Minneapolis, MN, ²Complex Care Analytics, Fairview Health Services, Minneapolis, MN
*Purpose: Induction regimens for kidney transplant (KT) in heart recipients vary widely among transplant centers. We sought to examine the impact of kidney induction type…
2019 American Transplant Congress
Evaluation of Rabbit Antithymocyte Globulin (rATG) Dosing and Incidence of Opportunistic Viral Infections in Kidney Transplant Recipients Using Tacrolimus (TAC), Mycophenolate (MPA) and Steroid Free Maintenance Immunosuppression
L. Von Stein, A. Leino, R. Amer, T. Pesavento, H. Winters
The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: There is limited literature evaluating rATG dosing and incidence of infection with TAC/MPA and early steroid withdrawal. This study evaluates rATG dosing and overall…
2019 American Transplant Congress
Incidence of Viral Infections in Kidney Transplant Recipients with Alemtuzumab or Rabbit Antithymocyte Globulin Induction
A. Brueckner¹, C. Truong¹, E. Yanqui¹, R. Baliga², L. Bowman¹
¹Tampa General Hospital, Tampa, FL, ²Florida Kidney Physicians, Tampa, FL
*Purpose: Monoclonal antibody therapy causes profound and sustained lymphocyte depletion thus increasing the risk of viral infections. While studies exist evaluating the outcomes of alemtuzumab…
2019 American Transplant Congress
Long-Term Outcomes of Elderly Living Donors: A Nationwide Population-Based Study
H. Yoon¹, Y. Kim², S. Shin¹, J. Ahn³, C. Yang¹, B. Chung¹
¹-The Catholic University of Korea, -Seoul, Korea, Republic of, ²Yonsei University Wonju College of Medicine, Wonju, Korea, Republic of, ³Department of Information & Statistics, Yonsei University, Wonju, Korea, Republic of
*Purpose: The organ shortage for kidney transplantation has increased the demand for living kidney donors, and elderly donors (> 60-years-old) have become more common. Long-term…
2019 American Transplant Congress
Facilitators and Barriers to Implementing the Live Donor Champion Program
A. D. Love¹, D. R. Helfer¹, S. Rasmussen¹, M. Johnson¹, J. M. Konel¹, J. R. Wellen², S. M. Nazarian³, E. King¹, D. L. Segev¹, T. Hwee¹, A. M. Cameron¹, M. L. Henderson¹, E. J. Gordon⁴, J. M. Garonzik Wang¹
¹Surgery, Johns Hopkins University, Baltimore, MD, ²Abdominal Transplant Surgery, Washington University School of Medicine, St. Louis, MO, ³Surgery, Penn Transplant Institute, Philadelphia, PA, ⁴Surgery, Northwestern Feinberg School of Medicine, Chicago, IL
*Purpose: The Live Donor Champion (LDC) Program is an intervention designed to increase kidney transplant candidate knowledge about living donor kidney transplantation (LDKT) and ability…
2019 American Transplant Congress
Correlates of Surgical Difficulty and Post-Operative Complications in Living Donor Kidney Procurement
B. I. Shaw¹, F. R. Schwartz², F. Vernucci², F. Rigiroli², F. Gonzalez², R. Lerebours³, A. S. Rege¹, D. Vikraman¹, D. Marin², K. V. Ravindra¹
¹Surgery, Duke University, Durham, NC, ²Radiology, Duke University, Durham, NC, ³Biostatistics, Duke University, Durham, NC
*Purpose: Living donor kidney donation is essential for decreasing waitlists for kidney transplantation. Though donor nephrectomy is a standard operation, there is a paucity of…
2019 American Transplant Congress
Distribution And Outcomes Of Donor Right Kidneys In A National Paired Kidney Exchange Program
G. Roll¹, W. Irish², M. Cooper³, M. Ronin⁴, G. Hil⁵, A. D. Waterman⁶, D. B. Leeser²
¹UCSF, San Francisco, CA, ²ECU, Greenville, NC, ³Georgetown Univ, Washington, DC, ⁴NKR, Babylon, CA, ⁵NKR, Babylon, NY, ⁶UCLA and Terasaki Research Institute, Los Angeles, CA
*Purpose: Left living donor kidneys for transplant (txp) are preferred to right living donor kidneys for longer renal vein length which decreases technical difficulty of…
2019 American Transplant Congress
Redefining Cirrhotic Cardiomyopathy; A Shifting Paradigm
M. J. Izzy¹, M. Angirekula², M. Leise², A. Allen², K. Watt²
¹Gastroenterology and Hepatology, Vanderbilt University Medical Center, Nashville, TN, ²Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN
*Purpose: Diastolic dysfunction (DD) is the hallmark of cirrhotic cardiomyopathy (CCM) for which criteria were established in 2005. Based on those criteria, the prevalence of…
2019 American Transplant Congress
Five Years after Right Hepatectomy for Living Liver Donation: Donor State of Health
D. P. Hoyer, E. Malamutmann, G. Bagias, A. Oezcelik
General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany
*Purpose: Of utmost importance in living liver donation is the avoidance of postoperative complications and reduction of quality of life of the donor.*Methods: Inclusion criteria…